Clinical Trial: Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856355) titled 'Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia' on Sept. 23.

Brief Summary: The TOP-MDRVAP trial will test whether inhaled tobramycin can safely prevent pneumonia caused by multidrug-resistant bacteria in adults who need a breathing machine. Tobramycin is an antibiotic. Multidrug-resistant bacteria are bacteria that resist treatment with several types of antibiotics. Pneumonia that develops in patients receiving breathing support through a breathing tube is called ventilator-associated pneumonia (VAP). This study will evaluate tobramycin as a preventive treatment, rather than as treatment for e...